These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3960261)

  • 1. [Preventive medical treatment of recurrent urinary calcium calculi].
    François B; Trolliet P; Cahen R; Semet MP
    Nephrologie; 1986; 7(1):9-12. PubMed ID: 3960261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative variations in natriuresis and urinary calcium in patients with hypercalciuric lithiasis treated with thiazide diuretics].
    Jungers P; Lacour B; Daniel J; Chauveau P; Bruneau M; Bailly M
    Nephrologie; 1984; 5(5):202-4. PubMed ID: 6531057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol.
    Maschio G; Tessitore N; D'Angelo A; Fabris A; Pagano F; Tasca A; Graziani G; Aroldi A; Surian M; Colussi G; Mandressi A; Trinchieri A; Rocco F; Ponticelli C; Minetti L
    Am J Med; 1981 Oct; 71(4):623-6. PubMed ID: 7282751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Randomized trials in the prevention of recurrent calcium oxalate stones].
    Presne C; Monge M; Bataille P; el Esper N; Choukroun G; Fournier A
    Nephrologie; 2003; 24(6):303-7. PubMed ID: 14584297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of recurrent nephrolithiasis.
    Goldfarb DS; Coe FL
    Am Fam Physician; 1999 Nov; 60(8):2269-76. PubMed ID: 10593318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria].
    Kurita Y; Kageyama S; Ishikawa A; Ushiyama T; Ohta N; Suzuki K; Kawabe K
    Hinyokika Kiyo; 1994 Jun; 40(6):479-83. PubMed ID: 8073954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].
    Ulmann A
    Nephrologie; 1984; 5(5):232-4. PubMed ID: 6531063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].
    Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of thiazide diuretics on carbohydrate-induced calciuria in patients with recurrent renal calculi.
    Wilson DR; Siddiqui AA; Ehrig U
    J Lab Clin Med; 1975 Jul; 86(1):118-25. PubMed ID: 239075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of urinary calcium and oxalate on three diets in patients with urolithiasis.
    Juuti M; Alhava EM
    Ann Clin Res; 1980 Dec; 12(6):320-5. PubMed ID: 7235608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T; Koide T; Oka T; Sakaguchi H; Itatani H; Ohkawa T; Ebisuno S; Morimoto S; Yoshida O; Okada Y
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.